Status: Not yet recruiting
A Study to Investigate the Pharmacokinetics and Safety of KM04 Compared to United States (US)-Gonal-f Revised Formulation Female (RFF) Redi-ject and European Union (EU)-Gonal-f in Healthy Adult Female Volunteers
A study to investigate the pharmacokinetics and safety of KM04 compared to United States (US)-Gonal-f Revised Formulation Female (RFF) Redi-ject and European Union (EU)-Gonal-f in healthy adult female volunteers
Participants needed: 42
Trial details
Phase: Phase 1Age: 18-40Biological sex: FemaleType: InterventionalSponsor: Xentria, Inc.Updated: Aug 31, 2026
Eligibility criteria
Participant must be 18 to 40 years of age inclusive, at the time of signing the... [+7]
Participant is pregnant, breastfeeding, or plans to become pregnant or breastfee... [+22]